News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

NVIDIA Corporation (NVDA) Graphics Power Groundbreaking Cancer-Detection Solution



2/21/2006 12:01:55 PM

SANTA CLARA, Calif., Feb. 21 /PRNewswire-FirstCall/ -- NVIDIA Corporation today announced that a groundbreaking cancer-detection system developed by Massachusetts General Hospital and Mercury Computer Systems has been recognized by Advanced Imaging Magazine with an "Imaging Solutions of the Year" award. NVIDIA Quadro(R) FX professional graphics solutions provide the processing power for the computationally-intense system.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020613/NVDALOGO )

Award winners were chosen based on the uniqueness of the challenge as well as on the creativity of their solution. Categories covered the spectrum -- from industrial and machine vision through space imaging and image visualization to medical, microscopy, military and commercial applications.

Massachusetts General Hospital developed the Digital Breast Tomosynthesis (DBT) imaging system and Mercury Computer Systems developed a high speed solution to permit rapid processing of the images. NVIDIA Quadro FX includes a unique programmable rendering pipeline that enables the reconstruction of a 3D volume from a series of 2D projection images.

"This award is a significant achievement in our collaboration with Mass General Hospital to improve cancer detection and diagnosis," said Marcelo Lima, vice president of Commercial Imaging and Visualization at Mercury Computer Systems. "With NVIDIA technology, we hope to take this promising DBT imaging technique from the laboratory to widespread clinical use."

Components of the system also include the Senographe 2000 Digital Mammography System from GE Healthcare and an advanced "likelihood expectation" algorithm co-developed by Brandeis University and Massachusetts General Hospital. The project was supported in part by two grants from the US Army Medical Research and Material Command.

DBT provides the advantage of enabling physicians to "page through" the interior of the breast without obstruction by surrounding superimposed tissue. In the past, the potential benefits of DBT were downplayed because the method was computationally intense and took far too long for use in a clinical setting. With the new system, computation time was reduced from five hours to five minutes, a 60x performance increase. In pre-clinical testing, the new DBT system permitted physicians to find cancers earlier and more easily, and to differentiate benign versus malignant lesions while simultaneously reducing false positives.

Advanced Imaging is dedicated to providing the latest information on imaging hardware, software and peripherals to qualified professionals working with all forms of electronic imaging. For more information on the "Imaging Solutions of the Year" awards, go to: http://www.advancedimagingpro.com/publication/article.jsp?pubId=1&id=2327 .

About NVIDIA

NVIDIA Corporation is the worldwide leader in programmable graphics processor technologies. The Company creates innovative, industry-changing products for computing, consumer electronics, and mobile devices. NVIDIA is headquartered in Santa Clara, CA and has offices throughout Asia, Europe, and the Americas. For more information, visit www.nvidia.com.

Certain statements in this press release including, but not limited to, widespread clinical use of the DBT imaging technique incorporating NVIDIA technology are forward-looking statements that are subject to risks and uncertainties that could cause results to be materially different than expectations. Such risks and uncertainties include, but are not limited to, continued market acceptance of new products and technologies, manufacturing delays or defects, software bugs, difficulties in the development of new and enhanced products and technologies, the impact of technological development, prohibitive expense and other risks detailed from time to time in the reports NVIDIA files with the Securities and Exchange Commission including its Form 10-Q for its quarter ended October 30, 2005. These forward-looking statements speak only as of the date of this release. NVIDIA disclaims any obligation to update these forward-looking statements.

NOTE: All company and/or product names may be trade names, trademarks and/or registered trademarks of the respective owners with which they are associated. Features, pricing, availability, and specifications are subject to change without notice.

Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20020613/NVDALOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk photodesk@prnewswire.comNVIDIA Corporation

CONTACT: David Higham of NVIDIA Corporation, +1-408-486-8287, ordhigham@nvidia.com


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES